Bioniq Enters Saudi Arabia with Strategic Partnership
Bioniq has entered the Saudi market with a partnership with Al Borg Diagnostics to provide personalized supplements based on blood test data across key Saudi cities. CEO Vadim Fedotov highlighted the company's focus on product efficacy and transparency, aiming to differentiate Bioniq from competitors with unverified claims. The partnership, launched in April this year, positions Saudi Arabia as a strategic location for Bioniq's regional expansion.
Bioniq, a company specializing in personalized supplements based on blood test data, has entered the Saudi market through a partnership with Al Borg Diagnostics.
The company's algorithm-driven health solutions will now be available in key cities across the Kingdom.
CEO Vadim Fedotov emphasized Bioniq's commitment to product efficacy and transparency, distinguishing it from competitors that offer unverified claims.
Future collaborations may include governmental bodies.
The company’s strategy focuses on strengthening local partnerships, enhancing customer experience, and expanding its presence in the Middle East and North Africa.
Bioniq’s launch in Saudi Arabia, marked by its partnership with Borg AI in April, introduced products like Bioniq GO and Bioniq PRO to the market.
Fedotov hinted at establishing a local office, emphasizing Saudi Arabia's strategic importance.
Founded in 2019 in London, Bioniq aims to address personalized health and wellness needs globally, leveraging strategic investments and partnerships.